This clinical trial is focused on studying the treatment of cholangiocarcinoma, a type of cancer that occurs in the bile ducts. The study is exploring two treatment methods: radiofrequency ablation and photodynamic therapy. Photodynamic therapy involves using a special drug called Porfimer Sodium, which is a photosensitizer, meaning it becomes active when exposed to light. Another drug used in this study is Foscan, which is administered as a solution for injection.
The purpose of the study is to determine whether photodynamic therapy or radiofrequency ablation leads to longer survival for patients with cholangiocarcinoma. Participants in the study will receive one of these treatments, and their progress will be monitored over time. The study will look at various aspects of the patients’ health, including their overall survival, quality of life, and how long they remain out of the hospital. The study will also consider other factors like the effectiveness of stents, which are small tubes used to keep the bile ducts open, and any changes in laboratory test results.
The study is expected to continue until the end of 2027, with the aim of gathering comprehensive data on the effectiveness of these treatments. By participating in this study, researchers hope to gain valuable insights into which treatment option may offer better outcomes for patients with cholangiocarcinoma.
Germany 
